Autologous Dendritic Cell Vaccination in Mesothelioma

Clinical trial NCT02649829 · COMPLETED

Trial details

NCT number: NCT02649829
Sponsor: University Hospital, Antwerp
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2017-10-03
Primary completion: 2025-03-09
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.